Mikiko Fukui

Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

Shin‐ichiro Fujii, Kanako Shimizu, Hiroaki Hemmi et al. · Proceedings of the National Academy of Sciences · 2006 · 168 citations · Full text

Glycolipid α-C-galactosylceramide, Glycolipid Triggers, Adaptive Immune System +25

Circulating anti‐MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer

Yuichiro Hamanaka, Yutaka Suehiro, Mikiko Fukui et al. · International Journal of Cancer · 2002 · 164 citations

MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.

Kotaro T. Yamamoto, Tomio Ueno, Toru Kawaoka et al. · PubMed · 2005 · 118 citations

Tumor Cells Loaded with α-Galactosylceramide Induce Innate NKT and NK Cell-Dependent Resistance to Tumor Implantation in Mice

Kanako Shimizu, Akira Gotō, Mikiko Fukui et al. · The Journal of Immunology · 2007 · 103 citations · Full text

Increased expression of MUC1 in advanced pancreatic cancer

Yuji Hinoda, Yoshito Ikematsu, Michiko Horinochi et al. · Journal of Gastroenterology · 2003 · 98 citations

Pancreatic Cancer, Medicine, Pathology +4